109 related articles for article (PubMed ID: 26566497)
1. The Association between Hypertension Comorbidity and Microvascular Complications in Type 2 Diabetes Patients: A Nationwide Cross-Sectional Study in Thailand.
Hurst C; Thinkhamrop B; Tran HT
Diabetes Metab J; 2015 Oct; 39(5):395-404. PubMed ID: 26566497
[TBL] [Abstract][Full Text] [Related]
2. Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort.
Song SH; Hardisty CA
QJM; 2009 Nov; 102(11):799-806. PubMed ID: 19734298
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of and factors related to microvascular complications in patients with type 2 diabetes mellitus in Tianjin, China: a cross-sectional study.
Bui HDT; Jing X; Lu R; Chen J; Ngo V; Cui Z; Liu Y; Li C; Ma J
Ann Transl Med; 2019 Jul; 7(14):325. PubMed ID: 31475195
[TBL] [Abstract][Full Text] [Related]
4. Predictors of microvascular complications in patients with type 2 diabetes mellitus at regional referral hospitals in the central zone, Tanzania: a cross-sectional study.
Shillah WB; Yahaya JJ; Morgan ED; Bintabara D
Sci Rep; 2024 Feb; 14(1):5035. PubMed ID: 38424145
[TBL] [Abstract][Full Text] [Related]
5. The Relationship Between Depression and Multifactorial Control and Microvascular Complications in Vietnamese with Type 2 Diabetes Mellitus Aged 30-60 Years.
Dinh Le T; Huy Duong H; Thi Nguyen L; Phi Thi Nguyen N; Tien Nguyen S; Van Ngo M
Diabetes Metab Syndr Obes; 2022; 15():1185-1195. PubMed ID: 35464259
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of patients with hypertension in a population with type 2 diabetes mellitus. Results from the Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Hypertension Study).
Sabuncu T; Sonmez A; Eren MA; Sahin I; Çorapçioğlu D; Üçler R; Akin Ş; Haymana C; Demirci İ; Atmaca A; Ersöz HÖ; Satman I; Bayram F;
Prim Care Diabetes; 2021 Apr; 15(2):332-339. PubMed ID: 33277201
[TBL] [Abstract][Full Text] [Related]
7. Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients.
Cyganek K; Mirkiewicz-Sieradzka B; Malecki MT; Wolkow P; Skupien J; Bobrek J; Czogala M; Klupa T; Sieradzki J
Acta Diabetol; 2006 Dec; 43(4):114-9. PubMed ID: 17211561
[TBL] [Abstract][Full Text] [Related]
8. Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?
Herrera-Pombo JL; Aguilar-Diosdado M; Hawkins F; Campos MM; Moreno A; Garcia-Hernandez A; Castro E; García-Doncel LG; Serraclara A; Sánchez-Malo C; Escobar-Jiménez F
Nephron Clin Pract; 2005; 101(3):c116-21. PubMed ID: 16015000
[TBL] [Abstract][Full Text] [Related]
9. Intensive blood pressure control affects cerebral blood flow in type 2 diabetes mellitus patients.
Kim YS; Davis SC; Truijen J; Stok WJ; Secher NH; van Lieshout JJ
Hypertension; 2011 Apr; 57(4):738-45. PubMed ID: 21357278
[TBL] [Abstract][Full Text] [Related]
10. Thailand diabetes registry project: type of diabetes, glycemic control and prevalence of microvascular complications in children and adolescents with diabetes.
Likitmaskul S; Wacharasindhu S; Rawdaree P; Ngarmukos C; Deerochanawong C; Suwanwalaikorn S; Chetthakul T; Bunnag P; Kosachunhanun N; Plengvidhaya N; Leelawatana R; Krittiyawong S; Benjasuratwong Y; Pratipanawatr T
J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S10-6. PubMed ID: 17715829
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and associated factors of vascular complications among inpatients with type 2 diabetes: A retrospective database study at a tertiary care department, Ningbo, China.
Li J; Chattopadhyay K; Xu M; Chen Y; Hu F; Chu J; Li L
PLoS One; 2020; 15(6):e0235161. PubMed ID: 32574208
[TBL] [Abstract][Full Text] [Related]
12. [Cardiovascular disease in patients with type 1 and type 2 diabetes in Spain].
Ortega E; Amor AJ; Rojo-Martínez G; Castell C; Giménez M; Conget I
Med Clin (Barc); 2015 Sep; 145(6):233-8. PubMed ID: 25561182
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and associating factors of atrial fibrillation in patients with hypertension: a nation-wide study.
Krittayaphong R; Rangsin R; Thinkhamrop B; Hurst C; Rattanamongkolgul S; Sripaiboonkij N; Yindeengam A
BMC Cardiovasc Disord; 2016 Mar; 16():57. PubMed ID: 27004563
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and determinants of microalbuminurea among type 2 diabetes mellitus patients, Baghdad, Iraq, 2013.
Ali AA; Al Lami FH
Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):348-55. PubMed ID: 26997390
[TBL] [Abstract][Full Text] [Related]
15. The influence of homocysteine levels on endothelial function and their relation with microvascular complications in T2DM patients without macrovascular disease.
Karabag T; Kaya A; Temizhan A; Koç F; Yavuz S; Cam S
Acta Diabetol; 2007 Jun; 44(2):69-75. PubMed ID: 17530470
[TBL] [Abstract][Full Text] [Related]
16. Progression from impaired fasting glucose to type 2 diabetes mellitus among Chinese subjects with and without hypertension in a primary care setting.
Fu SN; Luk W; Wong CK; Cheung KL
J Diabetes; 2014 Sep; 6(5):438-46. PubMed ID: 24393475
[TBL] [Abstract][Full Text] [Related]
17. Relationship between vitamin D status and vascular complications in patients with type 2 diabetes mellitus.
Jung CH; Kim KJ; Kim BY; Kim CH; Kang SK; Mok JO
Nutr Res; 2016 Feb; 36(2):117-24. PubMed ID: 26826427
[TBL] [Abstract][Full Text] [Related]
18. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited.
Orchard TJ; Forrest KY; Ellis D; Becker DJ
Arch Intern Med; 1997 Sep; 157(16):1851-6. PubMed ID: 9290544
[TBL] [Abstract][Full Text] [Related]
19. Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes.
Takata Y; Osawa H; Kurata M; Kurokawa M; Yamauchi J; Ochi M; Nishida W; Okura T; Higaki J; Makino H
Hypertension; 2008 Feb; 51(2):534-9. PubMed ID: 18180399
[TBL] [Abstract][Full Text] [Related]
20. Association Between Arterial Stiffness and Skin Microvascular Function: The SUVIMAX2 Study and The Maastricht Study.
van Sloten TT; Czernichow S; Houben AJ; Protogerou AD; Henry RM; Muris DM; Schram MT; Sep SJ; Dagnelie PC; van der Kallen CJ; Schaper NC; Blacher J; Hercberg S; Levy BI; Stehouwer CD
Am J Hypertens; 2015 Jul; 28(7):868-76. PubMed ID: 25523296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
